title: Report of chronic myeloid leukemia in chronic phase from All India Institute of Medical Sciences, 1990-2010.
abstract: All India Institute of Medical Sciences is an Apex Institute and caters more than 1.5 million out-patients and 80,000 in-patients every year. In this study, they have presented interesting results of patients treated with interferon, interferon plus cytarabine and then with imatinib plus cytarabine. They have presented data of 525 patients treated on imatinib alone. Imatinib dose was increased in 56 (10.6%) patients and regain of complete hematological response was seen in 26 patients. A total of 14 patients were transplanted for different indications of chronic myeloid leukemia and out of which 12 patients are doing well, while two died due to Grade IV gut graft-versus-host disease.
authors: Department of Hematology, All India Institute of Medical Sciences, New Delhi, India.
authors: Pravas
authors: P
authors: Mishra
authors: Department of Hematology, All India Institute of Medical Sciences, New Delhi, India.
authors: Tulika
authors: T
authors: Seth
authors: Department of Hematology, All India Institute of Medical Sciences, New Delhi, India.
authors: Manoranjan
authors: M
authors: Mahapatra
authors: Department of Hematology, All India Institute of Medical Sciences, New Delhi, India.
authors: Renu
authors: R
authors: Saxena
keywords: CML; Imatinib; Interferon